Jie Fu
- Molecular Biology top 10%
- Pharmacology top 2%
- Pharmacology top 1%
- Pharmaceutical Science top 1%
- Epidemiology top 10%
- Co-authors
- Justin HanesJian‐Dong JiangMing YangSamuel K. LaiYingying WangJia‐Wen ShouShurong MaYan Wang
- Topics
- Ferroptosis and cancer prognosis (9 papers)Liver Disease Diagnosis and Treatment (8 papers)Liver physiology and pathology (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jie Fu
123 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Molecular Biology 1.1k
- Pharmacology 416
- Pharmacology 315
- Pharmaceutical Science 309
- Epidemiology 299
Countries citing papers authored by Jie Fu
This map shows the geographic impact of Jie Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Fu more than expected).
Fields of papers citing papers by Jie Fu
This network shows the impact of papers produced by Jie Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Fu. The network helps show where Jie Fu may publish in the future.
Co-authorship network of co-authors of Jie Fu
This figure shows the co-authorship network connecting the top 25 collaborators of Jie Fu. A scholar is included among the top collaborators of Jie Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Fu. Jie Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 8 | |
| 9 | 6 | |
| 10 | 1 | |
| 11 | Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiotabreakdown → | 120 |
| 12 | Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiotabreakdown → | 240 |
| 13 | 4 | |
| 14 | 23 | |
| 15 | 6 | |
| 16 | 5 | |
| 17 | 360 | |
| 18 | Effect of Icarrin on cGMP levels in penile corous cavernosum of rabbit | 1 |
| 19 | Expression of phosphodiesterase 5 in clitoral corpus cavernosum and effect of icariin on cGMP levels in vitro | 1 |
| 20 | Studies on the Syntheses and Drug Release Properties of Polyanhydrides Containing Phosphonoformic(or Acetic)Acid Ethyl Ester in the Main Chain | 1 |
About Jie Fu
Jie Fu is a scholar working on Pharmacology, Hepatology and Cancer Research, having authored 133 papers that have together received 2.8k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Liver physiology and pathology (6 papers). The work is most often cited by research in Pharmaceutical Science (309 citations), Pharmacology (315 citations) and Biological Psychiatry (71 citations). Jie Fu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Justin Hanes, Jian‐Dong Jiang, Ming Yang, Samuel K. Lai, Yingying Wang, Jia‐Wen Shou, Shurong Ma, Yan Wang, Benjamin C. Tang and Pamela L. Zeitlin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.